|
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
RECRUITINGN/ASponsored by Methodist Health System
Actively Recruiting
PhaseN/A
SponsorMethodist Health System
Started2023-08-10
Est. completion2027-08
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06223633
Summary
The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Patients with acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter Exclusion Criteria: * Patients in whom antiplatelet agents or anticoagulation therapy is contraindicated. * Patients with a known allergy or hypersensitivity to amorphous silicon carbide or any other compound of the system (siloxane-based polyurethane, L-605 cobalt chromium alloy including tungsten and nickel). * Lesions that cannot be reached or treated with the system. * Lesions with threatened or abrupt closure during attempted pre-dilation prior to stent implantation. * Risk of treatment-related occlusion of vital coronary artery side branches. * Uncorrected bleeding disorders. * Allergy to contrast media.
Conditions2
Coronary DiseaseHeart Disease
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMethodist Health System
Started2023-08-10
Est. completion2027-08
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06223633